当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:738.16亿  总市值:738.97亿
流通股本:17.52亿   总股本:17.54亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金35,143,641,924.1923,043,949,397.089,882,552,619.7243,401,956,267.8
  收到的税费返还15,291,551.755,110,647.252,055,460.5511,647,283.25
  收到其他与经营活动有关的现金691,105,479.99311,722,673.58230,013,343.261,556,579,035.21
  经营活动现金流入小计35,850,038,955.9323,360,782,717.9110,114,621,423.5344,970,182,586.26
  购买商品、接受劳务支付的现金22,966,598,545.2513,943,183,727.917,695,820,108.3128,195,403,709.51
  支付给职工以及为职工支付的现金4,049,472,030.972,692,040,129.251,441,219,423.874,755,191,780.74
  支付的各项税费2,277,592,721.511,576,435,543.9671,816,951.082,574,487,192.25
  支付其他与经营活动有关的现金3,945,523,714.022,692,274,806.751,138,493,634.155,696,171,021.41
  经营活动现金流出小计33,239,187,011.7520,903,934,207.8110,947,350,117.4141,221,253,703.91
  经营活动产生的现金流量净额2,610,851,944.182,456,848,510.1-832,728,693.883,748,928,882.35
二、投资活动产生的现金流量:
  收回投资收到的现金14,700,000--1,000,000
  取得投资收益收到的现金49,321,490.4747,347,567.6743,350,00045,230,192.98
  处置固定资产、无形资产和其他长期资产收回的现金净额10,619,487.8310,814,966.499,751,90719,759,145.85
  收到的其他与投资活动有关的现金---261,016,721.64
  投资活动现金流入小计74,640,978.358,162,534.1653,101,907327,006,060.47
  购建固定资产、无形资产和其他长期资产支付的现金1,085,447,151.48788,358,827.36637,322,382.411,727,864,860.12
  投资支付的现金66,060,77561,560,77561,618,92569,176,613.4
  取得子公司及其他营业单位支付的现金---461,958,981.61
  支付其他与投资活动有关的现金1,524,947.75--238,277,274.34
  投资活动现金流出小计1,153,032,874.23849,919,602.36698,941,307.412,497,277,729.47
  投资活动产生的现金流量净额-1,078,391,895.93-791,757,068.2-645,839,400.41-2,170,271,669
三、筹资活动产生的现金流量:
  取得借款收到的现金2,519,372,6481,720,372,646.921,289,998,8484,559,775,187.36
  收到其他与筹资活动有关的现金220,601,111.1217,401,111.1146,000,000690,739,328.24
  筹资活动现金流入小计2,739,973,759.11,937,773,758.021,435,998,8485,250,514,515.6
  偿还债务支付的现金2,642,267,908.351,728,740,028.91,279,708,605.453,571,431,254.37
  分配股利、利润或偿付利息支付的现金1,758,448,442.051,057,608,222.2517,579,298.661,733,453,239.02
  其中:子公司支付给少数股东的股利、利润11,873,140.39--31,275,554.96
  支付其他与筹资活动有关的现金701,895,348.32684,856,705.37225,549,581.73695,294,341.33
  筹资活动现金流出小计5,102,611,698.723,471,204,956.521,522,837,485.846,000,178,834.72
  筹资活动产生的现金流量净额-2,362,637,939.62-1,533,431,198.5-86,838,637.84-749,664,319.12
四、汇率变动对现金及现金等价物的影响-6,921,970.54-116,843,004.4-3,115,685.5-47,001,718.46
五、现金及现金等价物净增加额-837,099,861.9114,817,239-1,568,522,417.63781,991,175.77
  加:期初现金及现金等价物余额4,990,151,186.684,990,151,186.684,990,151,186.684,208,160,010.91
  期末现金及现金等价物余额4,153,051,324.775,004,968,425.683,421,628,769.054,990,151,186.68
补充资料:
  净利润-1,803,329,008.97-3,494,185,631.76
  资产减值准备-83,959,366.71-153,185,473.56
  固定资产和投资性房地产折旧-300,346,213.46-473,271,554.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-300,346,213.46-473,271,554.08
  无形资产摊销-210,989,400.4-291,077,823.5
  长期待摊费用摊销-4,929,866.34-9,728,874.68
  处置固定资产、无形资产和其他长期资产的损失-6,201,002.36-5,463,399.18
  固定资产报废损失-1,867,728.04-2,033,665.48
  公允价值变动损失-0-0
  财务费用-55,530,243.83-87,246,657.66
  投资损失-35,365,772.99-82,799,888.43
  递延所得税--35,858,881.65--49,278,116.87
  其中:递延所得税资产减少--35,423,070.01--33,855,364.93
    递延所得税负债增加--435,811.64--15,422,751.94
  存货的减少--253,462,220.69--498,851,129.33
  经营性应收项目的减少--517,861,553.48--1,979,535,459.83
  经营性应付项目的增加-758,867,410.03-1,565,935,497.69
  其他-2,645,152.79-20,980,024.57
  现金的期末余额-5,004,968,425.68-4,990,151,186.68
  减:现金的期初余额-4,990,151,186.68-4,208,160,010.91
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额-14,817,239-781,991,175.77
公告日期2025-10-282025-08-202025-04-252025-04-18
审计意见(境内)标准无保留意见
TOP↑